Marshall Wace »

Black Diamond Therapeutics shares owned by Marshall Wace

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Marshall Wace

Quarter filed Position value Share count Share price at filing
2023-12-31 $64k 23k 2.81
2021-03-31 $3.4M 140k 24.26
2020-12-31 $1.4M 43k 32.06
2020-06-30 $338k 8.0k 42.21
2020-03-31 $718k 29k 24.94

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Amazon.com Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Spdr S&p 500 Etf Equity Option Call Option (SPY)
Alphabet Inc-a Equity Option Put Option (GOOGL)
Meta Platforms-a Common Stock (META)
Alphabet Inc-c Common Stock (GOOG)
Walmart Common Stock (WMT)
Abbvie Equity Option Put Option (ABBV)
Las Vegas Sands Common Stock (LVS)
Dr Horton Common Stock (DHI)
Ishares-leh 20 Equity Option Call Option (TLT)
Eli Lilly & Co Right Call Option
General Electric Common Stock (GE)

View all positions for Marshall Wace

Top funds holding Black Diamond Therapeutics

Bellevue Group
NEA Management Company
RA Capital Management
Vanguard Group
Tang Capital Management
BlackRock
Artal Group
Kennedy Capital Management
Blue Owl Capital Holdings
Ikarian Capital
Boxer Capital
Susquehanna International
Geode Capital Management
Two Sigma Investments
Verition Fund Management

View all funds holding Black Diamond Therapeutics